Page last updated: 2024-10-23

azathioprine and Preleukemia

azathioprine has been researched along with Preleukemia in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Preleukemia: Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.

Research Excerpts

ExcerptRelevanceReference
"Azathioprine has been associated with chromosome abnormalities."1.26Erythroleukemia in a renal transplant recipient. ( Baker, MA; deVeber, GA; Ellerton, JA, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ellerton, JA1
deVeber, GA1
Baker, MA1

Other Studies

1 other study available for azathioprine and Preleukemia

ArticleYear
Erythroleukemia in a renal transplant recipient.
    Cancer, 1979, Volume: 43, Issue:5

    Topics: Azathioprine; Chromosome Aberrations; Humans; Kidney Transplantation; Leukemia, Erythroblastic, Acut

1979